Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3

Sponsor Class

UNKNOWN 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 42Triple Negative Breast Neoplasms 9Neoplasm Metastasis 4Hormone Receptor Positive Advanced Breast Cancer 3HER2-positive Breast Cancer 3Recurrence 2Advanced Breast Cancer 2Skin Diseases 1Radiation Injuries 1Pathologic Complete Response 1Neoplasms by Site 1Lung Neoplasms 1Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1Heart Injuries 1Cardiovascular Diseases 1Carcinoma, Ductal, Breast 1Breast Diseases 1Breast Cancer Recurrent 1Brain Neoplasms 1

Interventions

palbociclib 1Vinorelbine 1Fulvestrant 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Hormone Receptor Positive Advanced Breast Cancer × Breast × Clear all
NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Unknown
600 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

NCT05343117 2022-04-26

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

ChineseAMS

Unknown
400 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

NCT03939871 2020-06-23

A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer

ChineseAMS

Phase 2 Unknown
30 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡